SEGMENT INFORMATION (Tables)

3 Months Ended

Mar. 31, 2022

Segment Reporting [Abstract]

Schedule of segment revenues and profit

Segment revenues and profits were as follows:

	Three Months Ended March 31,
(in millions)	2022		2021
Revenues:
Bausch + Lomb	$	889	$	881
Salix	464		472
International	244		306
Solta Medical	72		72
Diversified Products	249		296
	$	1,918	$	2,027
Segment profits:
Bausch + Lomb	$	206	$	239
Salix	322		327
International	91		109
Solta Medical	35		41
Diversified Products	158		200
	812		916
Corporate	(194)		(181)
Amortization of intangible assets	(310)		(357)
Goodwill impairments	—		(469)
Asset impairments, including loss on assets held for sale	(8)		(148)
Restructuring, integration, separation and IPO costs	(13)		(12)
Other income (expense), net	(2)		30
Operating income (loss)	285		(221)
Interest income	2		2
Interest expense	(362)		(368)
Loss on extinguishment of debt	—		(5)
Foreign exchange and other	(7)		1
Loss before provision for income taxes	$	(82)	$	(591)

Schedule of revenues by segment and product category

Revenues by segment and product category were as follows:

(in millions)	Bausch + Lomb		Salix		International		Solta Medical		Diversified Products		Total
	Three Months Ended March 31, 2022
Pharmaceuticals	$	110	$	464	$	65	$	—	$	205	$	844
Devices	386		—		—		72		—		458
OTC	335		—		38		—		2		375
Branded and Other Generics	52		—		133		—		36		221
Other revenues	6		—		8				6		20
	$	889	$	464	$	244	$	72	$	249	$	1,918
	Three Months Ended March 31, 2021
Pharmaceuticals	$	121	$	470	$	59	$	—	$	242	$	892
Devices	382		—		—		72		—		454
OTC	320		—		25		—		2		347
Branded and Other Generics	51		—		212		—		47		310
Other revenues	7		2		10		—		5		24
	$	881	$	472	$	306	$	72	$	296	$	2,027

Schedule of revenue attributed to a geographic region

Revenues are attributed to a geographic region based on the location of the customer and were as follows:

	Three Months Ended March 31,
(in millions)	2022		2021
U.S. and Puerto Rico	$	1,115	$	1,162
China	103		110
Canada	78		76
Poland	76		62
Mexico	61		69
France	57		54
Japan	51		60
Germany	45		42
United Kingdom	28		25
Russia	25		31
Spain	21		19
Italy	20		17
South Korea	19		20
Other	219		280
	$	1,918	$	2,027

Schedule of customers that accounted for 10% or more of total revenue

Customers that accounted for 10% or more of total revenues were as follows:

	Three Months Ended March 31,
	2022	2021
AmerisourceBergen Corporation	18%	18%
McKesson Corporation (including McKesson Specialty)	14%	16%
Cardinal Health, Inc.	13%	12%